ABS Direct Equity Fund’s Alkermes ALKS Stock Holding History

ABS Direct Equity Fund’s Portfolio ALKS Stock Details ALKS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-4,900	Closed	-$167K	–	112
2026 Q1	$167K	Buy	+4,900	New	+$152K	0.13%	91

Other funds holding ALKS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

ABS Direct Equity Fund's ALKS Position: Q2 2026 in Review

ABS Direct Equity Fund sold out of Alkermes (ALKS) in Q2 2026, closing a stake of 4,900 shares — an estimated $167K sold.

ABS Direct Equity Fund first reported a position in ALKS in Q1 2026 and held it in 1 quarter. The position peaked at $167K in Q1 2026. 424 funds tracked by Wall St. Rank hold ALKS as of Q2 2026.

ABS Direct Equity Fund reported no remaining Alkermes position as of Q2 2026 after selling out during the quarter.
ABS Direct Equity Fund sold 4,900 Alkermes shares in Q2 2026, an estimated $167K.
ABS Direct Equity Fund first reported a position in Alkermes in Q1 2026 and held it in 1 quarter.
ABS Direct Equity Fund's Alkermes position peaked at $167K in Q1 2026.
424 funds tracked by Wall St. Rank held Alkermes as of Q2 2026.

Based on ABS Direct Equity Fund's 13F filing for Q2 2026, filed 13 Aug 2026.